ATF6 and obesity disorder: These molecular alterations demonstrate that vascular risk in childhood obesity begins at the transcriptomic level long before clinical symptoms emerge, highlighting the <i>ATF6/PLAT</i> axis as a potential biomarker for early risk assessment.